Rosen Law Firm Reminds Investors of Deadline for Soleno Therapeutics Securities Fraud Lawsuit
Rosen Law Firm is reminding investors who purchased shares of Soleno Therapeutics, Inc. (NASDAQ: SLNO) between March 26, 2025, and November 4, 2025, of the May 5, 2026 deadline to become lead plaintiff in a securities fraud class action lawsuit. Investors may be eligible for compensation through a contingency fee arrangement without out-of-pocket costs.
Tickers: $SLNO
Topics: class action investor rights lead plaintiff deadline securities litigation